| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5280036
Max Phase: Preclinical
Molecular Formula: C23H27F3N2O3
Molecular Weight: 436.47
Associated Items:
Representations
Canonical SMILES: COc1cccc(C2(O)CCN(C(=O)Cc3cc(F)c(F)cc3F)CC2CN(C)C)c1
Standard InChI: InChI=1S/C23H27F3N2O3/c1-27(2)13-17-14-28(22(29)10-15-9-20(25)21(26)12-19(15)24)8-7-23(17,30)16-5-4-6-18(11-16)31-3/h4-6,9,11-12,17,30H,7-8,10,13-14H2,1-3H3
Standard InChI Key: AYIFYIHXAMCCQF-UHFFFAOYSA-N
Associated Targets(Human)
Delta opioid receptor 15096 Activities
Kappa opioid receptor 16155 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Mu opioid receptor 6060 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mus musculus 284745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 436.47 | Molecular Weight (Monoisotopic): 436.1974 | AlogP: 2.95 | #Rotatable Bonds: 6 |
| Polar Surface Area: 53.01 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.71 | CX Basic pKa: 8.76 | CX LogP: 2.50 | CX LogD: 1.12 |
| Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.71 | Np Likeness Score: -0.72 |
References
| 1. Huang H, Li X, Xie P, Li X, Xu X, Qian Y, Yuan C, Meng X, Chai J, Chen J, Liu J, Wang W, Li W, Wang Y, Fu W, Liu J.. (2021) Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic., 64 (13.0): [PMID:34152138] [10.1021/acs.jmedchem.1c00722] |
Source
Source(1):